Effects of cinobufacini injection on cell proliferation and the expression of topoisomerases in human HepG-2 hepatocellular carcinoma cells

被引：30

作者：

Liu, Ying ^{[1
]}

Ban, Li-Ying ^{[1
]}

Su, Xi ^{[1
]}

Gao, Shan ^{[1
]}

Liu, Ji-Wei ^{[1
]}

Cui, Xiao-Nan ^{[1
]}

机构：

[1] Dalian Med Univ, Affiliated Hosp 1, Dept Oncol, Dalian 116011, Liaoning, Peoples R China

来源：

MOLECULAR MEDICINE REPORTS | 2015年 / 12卷 / 01期

基金：

中国国家自然科学基金;

关键词：

cinobufacini injection; HepG-2; cells; proliferation; apoptosis; topoisomerase I; topoisomerase II; PROSTATE-CANCER CELLS; DNA; BUFALIN; APOPTOSIS; HUACHANSU; PATHWAYS; THERAPY; DEATH; PHASE;

D O I：

10.3892/mmr.2015.3552

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

The present study aimed to investigate the effects of cinobufacini injection on the proliferation and expression of topoisomerases in human HepG-2 hepatocarcinoma cells. The cells were divided into a control group and an experimental group, in which 0.105, 0.21, 0.42 mg/l cinobufacini was injected. Cell proliferation was assessed using a 3-(4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide assay, levels of apoptosis were detected using annexin V/propidium iodide staining and cell cycles were analyzed using flow cytometric analysis. The mRNA and protein expression levels of topoisomerase (TOPO) I and TOPO II were determined by reverse transcription-quantitative polymerase chain reaction and western blotting, respectively. Cinobufacini injection significantly inhibited the proliferation of the HepG-2 cells (P<0.05), induced apoptosis (P<0.05) in a dose- and time-dependent manner, induced tumor cell arrest at the S phase in a dose-dependent manner, and downregulated the mRNA and protein expression levels of TOPO I and TOPO II (P<0.05) in a dose-dependent manner. Therefore, cinobufacini was found to inhibit human HepG-2 hepatocellular carcinoma cell proliferation, and downregulation of the expression levels of TOPO I and TOPO II may contribute to the effect on proliferation observed in the Hep-G(2) cells following cinobbufacini injection.

引用

页码：1598 / 1604

页数：7

共 32 条

[1]

[Anonymous], J ONCOL

[2]

Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells [J].

Belluti, S. ;

Basile, V. ;

Benatti, P. ;

Ferrari, E. ;

Marverti, G. ;

Imbriano, C. .

CELL DEATH & DISEASE, 2013, 4 :e756-e756

[3]

BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3

[4]

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial [J].

Cheng, Ann-Lii ;

Kang, Yoon-Koo ;

Chen, Zhendong ;

Tsao, Chao-Jung ;

Qin, Shukui ;

Kim, Jun Suk ;

Luo, Rongcheng ;

Feng, Jifeng ;

Ye, Shenglong ;

Yang, Tsai-Sheng ;

Xu, Jianming ;

Sun, Yan ;

Liang, Houjie ;

Liu, Jiwei ;

Wang, Jiejun ;

Tak, Won Young ;

Pan, Hongming ;

Burock, Karin ;

Zou, Jessie ;

Voliotis, Dimitris ;

Guan, Zhongzhen .

LANCET ONCOLOGY, 2009, 10 (01) :25-34

[5]

Cui X, 2004, QINGDAO MED J, V36, P434

[6]

Dual topoisomerase I/II inhibitors in cancer therapy [J].

Denny, WA ;

Baguley, BC .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (03) :339-353

[7]

Identification of a Novel Topoisomerase Inhibitor Effective in Cells Overexpressing Drug Efflux Transporters [J].

Fayad, Walid ;

Fryknas, Marten ;

Brnjic, Slavica ;

Olofsson, Maria Haegg ;

Larsson, Rolf ;

Linder, Stig .

PLOS ONE, 2009, 4 (10)

[8]

DNA TOPOISOMERASE-I TARGETED CHEMOTHERAPY OF HUMAN-COLON CANCER IN XENOGRAFTS [J].

GIOVANELLA, BC ;

STEHLIN, JS ;

WALL, ME ;

WANI, MC ;

NICHOLAS, AW ;

LIU, LF ;

SILBER, R ;

POTMESIL, M .

SCIENCE, 1989, 246 (4933) :1046-1048

[9]

Gong Z. P., 2010, CHIN J EXP TRADIT ME, V16, P120

[10]

Hofland K, 2000, CLIN CANCER RES, V6, P1488

← 1 2 3 4 →